178 related articles for article (PubMed ID: 28905666)
1. Second Opinion Expert Pathology Review in Bladder Cancer: Implications for Patient Care.
Gordetsky J; Collingwood R; Lai WS; Del Carmen Rodriquez Pena M; Rais-Bahrami S
Int J Surg Pathol; 2018 Feb; 26(1):12-17. PubMed ID: 28905666
[TBL] [Abstract][Full Text] [Related]
2. Impact of second opinion pathology in the definitive management of patients with bladder carcinoma.
Coblentz TR; Mills SE; Theodorescu D
Cancer; 2001 Apr; 91(7):1284-90. PubMed ID: 11283928
[TBL] [Abstract][Full Text] [Related]
3. The impact of histological reclassification during pathology re-review--evidence of a Will Rogers effect in bladder cancer?
Linder BJ; Boorjian SA; Cheville JC; Sukov WR; Thapa P; Tarrell RF; Frank I
J Urol; 2013 Nov; 190(5):1692-6. PubMed ID: 23707452
[TBL] [Abstract][Full Text] [Related]
4. Staging and reporting of urothelial carcinoma of the urinary bladder.
Cheng L; Montironi R; Davidson DD; Lopez-Beltran A
Mod Pathol; 2009 Jun; 22 Suppl 2():S70-95. PubMed ID: 19494855
[TBL] [Abstract][Full Text] [Related]
5. Tumour front inflammation and necrosis are independent prognostic predictors in high-grade urothelial carcinoma of the bladder.
Hodgson A; Xu B; Satkunasivam R; Downes MR
J Clin Pathol; 2018 Feb; 71(2):154-160. PubMed ID: 28768702
[TBL] [Abstract][Full Text] [Related]
6. Urothelial tumours of the urinary bladder: a histopathological study of cystoscopic biopsies.
Vaidya S; Lakhey M; K C S; Hirachand S
JNMA J Nepal Med Assoc; 2013; 52(191):475-8. PubMed ID: 24907954
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of preoperative urinary smear test in patients with bladder urothelial carcinoma in a high-volume center.
Restrepo-Gonzalez JA; Garcia-Perdomo HA; Varela R
Arch Esp Urol; 2014 Apr; 67(3):243-8. PubMed ID: 24840589
[TBL] [Abstract][Full Text] [Related]
8. Second opinion and discrepancy in the diagnosis of soft tissue lesions at surgical pathology.
Sharif MA; Hamdani SN
Indian J Pathol Microbiol; 2010; 53(3):460-4. PubMed ID: 20699503
[TBL] [Abstract][Full Text] [Related]
9. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS
J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
[TBL] [Abstract][Full Text] [Related]
10. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
Kunju LP; You L; Zhang Y; Daignault S; Montie JE; Lee CT
J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
[TBL] [Abstract][Full Text] [Related]
11. Grading and staging of bladder carcinoma in transurethral resection specimens. Correlation with 105 matched cystectomy specimens.
Cheng L; Neumann RM; Weaver AL; Cheville JC; Leibovich BC; Ramnani DM; Scherer BG; Nehra A; Zincke H; Bostwick DG
Am J Clin Pathol; 2000 Feb; 113(2):275-9. PubMed ID: 10664630
[TBL] [Abstract][Full Text] [Related]
12. The role of pathology review of transurethral bladder tumor resection specimens in the modern era.
Lee MC; Levin HS; Jones JS
J Urol; 2010 Mar; 183(3):921-7. PubMed ID: 20089271
[TBL] [Abstract][Full Text] [Related]
13. Stage T1 bladder cancer: diagnostic criteria and pitfalls.
Lopez-Beltran A; Cheng L
Pathology; 2021 Jan; 53(1):67-85. PubMed ID: 33153725
[TBL] [Abstract][Full Text] [Related]
14. Upstaging of urothelial cancer at the time of radical cystectomy: factors associated with upstaging and its effect on outcome.
Turker P; Bostrom PJ; Wroclawski ML; van Rhijn B; Kortekangas H; Kuk C; Mirtti T; Fleshner NE; Jewett MA; Finelli A; Kwast TV; Evans A; Sweet J; Laato M; Zlotta AR
BJU Int; 2012 Sep; 110(6):804-11. PubMed ID: 22321341
[TBL] [Abstract][Full Text] [Related]
15. Relevance of prostate cancer in patients with synchronous invasive bladder urothelial carcinoma: a monocentric retrospective analysis.
Dell'Atti L
Arch Ital Urol Androl; 2015 Mar; 87(1):76-9. PubMed ID: 25847902
[TBL] [Abstract][Full Text] [Related]
16. Breast pathology review: does it make a difference?
Romanoff AM; Cohen A; Schmidt H; Weltz CR; Jaffer SM; Nagi CS; Bleiweiss IJ; Port ER
Ann Surg Oncol; 2014 Oct; 21(11):3504-8. PubMed ID: 24859936
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of atypical urine cytology progression to malignancy.
Muus Ubago J; Mehta V; Wojcik EM; Barkan GA
Cancer Cytopathol; 2013 Jul; 121(7):387-91. PubMed ID: 23536358
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity of initial biopsy or transurethral resection of bladder tumor(s) for detecting histological variants on radical cystectomy.
Ge P; Wang ZC; Yu X; Lin J; He Q
BMC Urol; 2015 May; 15():46. PubMed ID: 26025446
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of vascular endothelial growth factors A, C and D as indicators of lymphangiogenesis and angiogenesis in invasive and non-invasive urothelial carcinoma bladder.
Khadim MT; Ahmed SA; Khan FA; Ikram A; Shaikh SY
J Pak Med Assoc; 2015 Aug; 65(8):851-6. PubMed ID: 26228330
[TBL] [Abstract][Full Text] [Related]
20. Variant (divergent) histologic differentiation in urothelial carcinoma is under-recognized in community practice: impact of mandatory central pathology review at a large referral hospital.
Shah RB; Montgomery JS; Montie JE; Kunju LP
Urol Oncol; 2013 Nov; 31(8):1650-5. PubMed ID: 22608543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
